Mettler-Toledo (MTD) Financial Analysis & Valuation | Quarter Chart
Mettler-Toledo International Inc. engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include labo... more
Mettler-Toledo International Inc. engages in the manufacture and supply of precision instruments and... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $33.15B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Diagnostics & Research |
| Country | US | CEO | Patrick K. Kaltenbach |
| IPO Date | 1997-11-14 | CAGR | 5.59% |
| Employees | 16,600 | Website | www.mt.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 2.19% | Total Yield | 2.19% |
MTD chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $30.79B | P/E | 38.31 | Forward P/E | 31.32 | PEG | 2.22 |
| P/S | 8.5 | P/B | 458.14 | P/CF | 36.15 | P/FCF | 41.01 |
| Sales | $4.20B | Sales 1Y | 6.51% | Sales 3Y | 7.35% | Sales 5Y | 16.02% |
| EPS | $43.51 | EPS 1Y | 15.09% | EPS 3Y | 17.64% | EPS 5Y | 44.63% |
| Sales QoQ | 6.52% | EPS QoQ | 6.41% | Sales QoQ Avg | 2.13% | EPS QoQ Avg | 9.23% |
| Gross Margin | 59% | Operating Margin | 28.45% | Profit Margin | 22.25% | ROCE | 48.85% |
| ROA | 25% | ROE | 14966% | Altman Z Score | 11.63 | Piotroski Score | 8 |
| Current Ratio | 1.1 | Quick Ratio | 0.75 | Cash Ratio | 0.04 | Op. CF Ratio | 0.25 |
| Debt/Equity | 26.06 | Debt/Assets | 0.55 | Lt Debt/Equity | 25.28 | Lt Debt/Cap. | 0.96 |
| Intrst Cov. | 17.75 | Inventory Turnover | 3.92 | Asset Turnover | 1.14 | Receivables Turnover | 5.73 |
| Enterprise Value | $30.79B | P/E Ratio | 38.31 |
| Forward P/E | 31.32 | PEG Ratio | 2.22 |
| P/S Ratio | 8.5 | P/B Ratio | 458.14 |
| P/CF Ratio | 36.15 | P/FCF Ratio | 41.01 |
| EPS | $43.51 | EPS Growth 1Y | 15.09% |
| EPS Growth 3Y | 17.64% | EPS Growth 5Y | 44.63% |
| Revenue Growth 1Y | 6.51% | Gross Margin | 59% |
| Operating Margin | 28.45% | Profit Margin | 22.25% |
| ROE | 14966% | ROA | 25% |
| ROCE | 48.85% | Current Ratio | 1.1 |
| Quick Ratio | 0.75 | Cash Ratio | 0.04 |
| Debt/Equity | 26.06 | Interest Coverage | 17.75 |
| Altman Z Score | 11.63 | Piotroski Score | 8 |
Mettler-Toledo (MTD) valuation & financials
Mettler-Toledo (MTD) has a market capitalization of $33.15B and trades at a price-to-earnings ratio of 38.3. It operates in the Healthcare sector (Medical - Diagnostics & Research).
Mettler-Toledo's revenue grew +6.5% over the last year.
Mettler-Toledo's next earnings report is scheduled for February 4, 2027 after market close (provider scheduled date); analysts estimate EPS of $14.95. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)